Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person p-6Y-ERBB2 H878Y [plasma membrane]

Class:IdEntityWithAccessionedSequence:9647215
_displayNamep-6Y-ERBB2 H878Y [plasma membrane]
_timestamp2019-08-01 15:27:09
compartment[Compartment:876] plasma membrane
created[InstanceEdit:9647197] Orlic-Milacic, Marija, 2019-05-30
crossReference[DatabaseIdentifier:9646843] COSMIC:COSV54066178
disease[Disease:1500689] cancer
[Disease:1500576] breast cancer
[Disease:2327993] hepatocellular carcinoma
[Disease:9646847] urinary system cancer
endCoordinate1255
hasModifiedResidue[ReplacedResidue:9646820] L-histidine 878 replaced with L-tyrosine
[ModifiedResidue:1248700] O4'-phospho-L-tyrosine at 1023
[ModifiedResidue:1248685] O4'-phospho-L-tyrosine at 1139
[ModifiedResidue:1248708] O4'-phospho-L-tyrosine at 1196
[ModifiedResidue:1248692] O4'-phospho-L-tyrosine at 1221
[ModifiedResidue:1248701] O4'-phospho-L-tyrosine at 1222
[ModifiedResidue:1248689] O4'-phospho-L-tyrosine at 1248
[ModifiedResidue:9656347] O4'-phospho-L-tyrosine at 878
literatureReference[LiteratureReference:9646964] Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor
[LiteratureReference:9646962] Phosphorylation of mutationally introduced tyrosine in the activation loop of HER2 confers gain-of-function activity
[LiteratureReference:9649397] Differential sensitivity of ERBB2 kinase domain mutations towards lapatinib
modified[InstanceEdit:9649412] Orlic-Milacic, Marija, 2019-06-13
[InstanceEdit:9656350] Orlic-Milacic, Marija, 2019-08-01
namep-6Y-ERBB2 H878Y
p-6Y-HER2 H878Y
p-6Y-ERBB2 His878Tyr
p-6Y-HER2 His878Tyr
referenceEntity[ReferenceGeneProduct:54422] UniProt:P04626 ERBB2 [Homo sapiens]
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:9647219] R-HSA-9647215.1
startCoordinate23
(hasCandidate)[CandidateSet:9647244] p-6Y-ERBB2 KD mutants [plasma membrane] [Homo sapiens]
(hasMember)[CandidateSet:9654839] p-6Y-ERBB2 H878Y,(p-6Y-ERBB2 H878R) [plasma membrane] [Homo sapiens]
[CandidateSet:9664610] p-6Y-ERBB2 KD mutants (EGFR,ERBB3) [plasma membrane] [Homo sapiens]
[CandidateSet:9664920] p-6Y-ERBB2 KD mutants (EGFR,PI3K) [plasma membrane] [Homo sapiens]
[CandidateSet:9664999] p-6Y-ERBB2 KD mutants (EGFR,RAS) [plasma membrane] [Homo sapiens]
[CandidateSet:9665035] p-6Y-ERBB2 KD mutants (EGFR,PLCG1) [plasma membrane] [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by p-6Y-ERBB2 H878Y [plasma membrane] (9647215)